SAB Biotherapeutics Statistics
Total Valuation
SABS has a market cap or net worth of $35.81 million. The enterprise value is -$1.90 million.
Important Dates
The next estimated earnings date is Monday, November 11, 2024, after market close.
Earnings Date | Nov 11, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
SABS has 9.23 million shares outstanding. The number of shares has increased by 61.54% in one year.
Shares Outstanding | 9.23M |
Shares Change (YoY) | +61.54% |
Shares Change (QoQ) | +0.14% |
Owned by Insiders (%) | 16.26% |
Owned by Institutions (%) | 19.92% |
Float | 5.99M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 8.94 |
Forward PS | n/a |
PB Ratio | 0.65 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.24, with a Debt / Equity ratio of 0.12.
Current Ratio | 5.24 |
Quick Ratio | 4.97 |
Debt / Equity | 0.12 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -144.41 |
Financial Efficiency
Return on equity (ROE) is -122.49% and return on invested capital (ROIC) is -75.23%.
Return on Equity (ROE) | -122.49% |
Return on Assets (ROA) | -58.80% |
Return on Capital (ROIC) | -75.23% |
Revenue Per Employee | $48,773 |
Profits Per Employee | -$707,373 |
Employee Count | 57 |
Asset Turnover | 0.06 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.20% in the last 52 weeks. The beta is 0.70, so SABS's price volatility has been lower than the market average.
Beta (5Y) | 0.70 |
52-Week Price Change | -61.20% |
50-Day Moving Average | 2.80 |
200-Day Moving Average | 3.68 |
Relative Strength Index (RSI) | 70.74 |
Average Volume (20 Days) | 135,384 |
Short Selling Information
The latest short interest is 79,819, so 0.86% of the outstanding shares have been sold short.
Short Interest | 79,819 |
Short Previous Month | 41,472 |
Short % of Shares Out | 0.86% |
Short % of Float | 1.33% |
Short Ratio (days to cover) | 1.53 |
Income Statement
In the last 12 months, SABS had revenue of $2.78 million and -$40.32 million in losses. Loss per share was -$5.29.
Revenue | 2.78M |
Gross Profit | -20.31M |
Operating Income | -45.79M |
Pretax Income | -40.32M |
Net Income | -40.32M |
EBITDA | -40.91M |
EBIT | -45.79M |
Loss Per Share | -$5.29 |
Full Income Statement Balance Sheet
The company has $37.33 million in cash and $5.34 million in debt, giving a net cash position of $31.98 million or $3.47 per share.
Cash & Cash Equivalents | 37.33M |
Total Debt | 5.34M |
Net Cash | 31.98M |
Net Cash Per Share | $3.47 |
Equity (Book Value) | 46.12M |
Book Value Per Share | 5.00 |
Working Capital | 32.03M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$37.08 million and capital expenditures -$334,755, giving a free cash flow of -$37.42 million.
Operating Cash Flow | -37.08M |
Capital Expenditures | -334,755 |
Free Cash Flow | -37.42M |
FCF Per Share | -$4.05 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -1,647.04% |
Pretax Margin | -1,450.33% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -1,344.30% |
Dividends & Yields
SABS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -61.54% |
Shareholder Yield | -61.54% |
Earnings Yield | -134.01% |
FCF Yield | -124.36% |
Analyst Forecast
The average price target for SABS is $12.40, which is 219.59% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $12.40 |
Price Target Difference | 219.59% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on January 5, 2024. It was a reverse split with a ratio of 0.1:1.
Last Split Date | Jan 5, 2024 |
Split Type | Reverse |
Split Ratio | 0.1:1 |
Scores
SABS has an Altman Z-Score of -2.47 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -2.47 |
Piotroski F-Score | 2 |